In addition, we can utilize the epigenetic regulation of Tregs, particularly the manipulation of methylation, histone modifications and post-translational modification of FOXP3, to abrogate its suppressive function while preserving its survival capacity for achieving anti-tumor efficacy. The gene discussed is FOXP3; the disease is neoplasm.